Subscribe To
Synchrony (syf) ties up to better serve the hearing care space
Synchrony Financial (SYF) aims to extend financing options to customers of Miracle-Ear who are in need ...
June 21, 2023, 3:34 pm
Vaccitech to present positive final data at easl congress for phase 1b/2 hbv002 study in adults with chronic hepatitis b
OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc...
June 21, 2023, 9:03 am
Liberty braves: a catalyst-driven home run
The Atlanta Braves represent a unique and scarce asset with significant brand value, offering potential for market-beating returns upon a sale of the ...
June 21, 2023, 4:17 am
Lilly to present new research in the treatment of diabetes and obesity at the american diabetes association's® 83rd scientific sessions
Full SURMOUNT-2 phase 3 data on the efficacy and safety of tirzepatide for chronic weight management in...
June 20, 2023, 1:37 pm
Eli lilly to buy dice therapeutics in $2.4 billion autoimmune disease push
Lilly said its acquisition of Dice for $48 a share would allow it to leverage the group's developing treatments for ...
June 20, 2023, 7:06 am
Back to basics: 3 undervalued non-tech stocks to buy now
With the rise of artificial intelligence and other digital innovations offering myriad efficiencies and conveniences, the idea of deliberately seeking...
June 19, 2023, 4:50 pm
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Why shares of schrödinger rose this week
Schrödinger focuses on drug discovery using an AI platform. The company has already helped bring two therapies to market....
June 16, 2023, 1:20 pm
The secrets of the s curve: why bitcoin adoption takes longer than you think
Like with the innovation of the chronometer, Bitcoin has qualities that will see relatively slow but in...
June 16, 2023, 12:44 pm
Scilex holding company to present data on elyxyb™ (celecoxib oral solution) at the 65th annual scientific meeting of the american headache society, in austin, tx.
PALO ALTO, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Ther...
June 16, 2023, 9:00 am
Blk dnm introduces intelligence into clothing with blockchain
Swedish-American fashion brand BLK DNM today unveils the first-ever example of connected fashion (garments that exist both physically and virtually, e...
June 15, 2023, 8:30 pm
Eye care surgical devices market expected to hit us$ 10.7 billion by 2031, growing at 5.5% cagr, tmr study
Growing prevalence of chronic diseases, is another factor that is anticipated to stimulate the eye care...
June 15, 2023, 8:30 pm
Revolut suffers another valuation hit as molten ventures cuts stake by 40%
Revolut is enduring another blow to its valuation as tech-focused investment firm Molten Venture has written down its stake in the London-headquartere...
June 15, 2023, 3:26 pm
Anemia, chronic renal disease and chronic heart failure: the cardiorenal anemia syndrome
The mortality and morbidity of congestive heart failure (CHF) have improved slightly over the years but are still very high. Many patients with CHF ar...
June 15, 2023, 1:46 pm
Bitkeep announces integration with quickswap, revolutionizes web3 trading with bitkeep swap
NEW YORK CITY, NY , June 14, 2023 (GLOBE NEWSWIRE) — The collaboration between BitKeep and QuickSwap brings forth a new era of seamless and efficien...
June 14, 2023, 7:00 pm
